FDA proposes framework clinical trial designs to guide Bayesian methods, improving efficiency in drug development for rare and pediatric conditions.

Get your news from a source that’s not owned and controlled by oligarchs. Sign up for the free Mother Jones Daily. It is really, really hard to find stuff to write about other than the C19 pandemic.

Researchers have employed Bayesian neural network approaches to evaluate the distributions of independent and cumulative ...